Presentation at the ICS 2024
Presentation at the Congress of the ICS 2024 (International Continence Society) in Madrid, Spain, 23-25 October, 2024.
Julien Ratelade from EG427 presented the results of a project performed in collaboration with Pelvipharm:
“EG110A, a novel non-replicative HSV1-derived vector expressing the light chain of botulinum toxin F, shows dose-dependent efficacy in an acute intravesical capsaicin rat model”.
Ratelade J, Epstein A, Denys P, Giuliano F, Haag-Molkenteller C, Salot S.
Best in Category Prize: Research Methods / Techniques
Continence 12S (2024) 101375
